IMB Dx, Inc. (KOSDAQ:461030)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,640.00
+60.00 (0.63%)
Apr 24, 2025, 3:30 PM KST
-49.92%
Market Cap 135.13B
Revenue n/a
Net Income n/a
Shares Out 14.02M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 74,075
Average Volume 77,449
Open 9,560.00
Previous Close 9,580.00
Day's Range 9,340.00 - 9,700.00
52-Week Range 7,710.00 - 23,500.00
Beta n/a
RSI 50.64
Earnings Date n/a

About IMB Dx

IMB Dx, Inc. provides liquid biopsy platform in South Korea. It offers AlphaLiquid Platform that provides circulation-tumor DNA-based precision diagnostics solutions across various stages of cancer for patients, survivors, and individuals; and AlphaLiquid 100 test, a tool that enables the detection of biomarkers across 118 cancer-related genes through one blood test. The company also provides CancerDetect, a liquid biopsy platform for the early detection of cancer recurrence post-surgery; and CancerFind, a blood-based test for various cancer ea... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 461030
Full Company Profile

News

There is no news available yet.